Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Magnetic resonance imaging (MRI) scanners have been used since the 1980s to take detailed images inside the body – helping doctors to make a medical diagnosis and investigate the staging of a disease.
An international team of researchers, led by Dr Munitta Muthana from the University of Sheffield’s Department of Oncology, have now found MRI scanners can non-invasively steer cells, which have been injected with tiny super-paramagnetic iron oxide nanoparticles (SPIOs), to both primary and secondary tumour sites within the body.
This targeted approach is extremely beneficial for patients as it dramatically increases the efficiency of treatment and drug doses could potentially be reduced – helping to alleviate side effects.
Revolutionary cell-based therapies, which exploit modified human cells to treat diseases such as cancer, have advanced greatly over recent years. However, targeted application of cell-based therapy in specific tissues, such as those lying deep in the body where injection is not possible, has remained problematic.
The new research suggests MRI scanners are the key to administering treatments directly to both primary and secondary tumours wherever they are located in the body.
The study, published today (date) in Nature Communications shows that cancer mouse models injected with immune cells carrying SPIOs and armed with the cancer killing oncolytic virus (OV) which infects and kills cancer cells, showed an 800 per cent increase in the effects of the therapy.
Dr Munitta Muthana, from the University of Sheffield, said: “Our results suggest that it is possible to use a standard MRI scanner to naturally deliver cell-based therapies to both primary and secondary tumours which would normally be impossible to reach by injection.
“This not only increases the therapeutic efficacy but also decreases the risk of unwanted side effects.
“The beauty of using the MRI scanner to administer the therapy is that you can also use it for its original purpose providing a real-time image-guide to ensure the treatment has gone where it is needed.”
The Latest on: Tumour busting therapies
via Google News
The Latest on: Tumour busting therapies
- Focused ultrasound shows promise against glioblastoma: Studyon June 25, 2020 at 7:29 am
An innovative use of focused ultrasound being pioneered at the University of Virginia School of Medicine is showing promise against glioblastoma, the deadliest brain tumor, and could prove ...
- Focused ultrasound shows promise against deadliest brain tumoron June 22, 2020 at 6:11 pm
“Sonodynamic therapy with focused ultrasound offers a new therapeutic approach to treating patients with malignant brain tumors,” said UVA Health neurosurgeon Jason Sheehan, MD, PhD.
- Focused ultrasound shows promise against deadliest brain tumoron June 22, 2020 at 7:47 am
An innovative use of focused ultrasound being pioneered at the University of Virginia School of Medicine is showing promise against glioblastoma, the deadliest brain tumor, and could prove useful ...
- Innovative use of focused ultrasound shows promise against glioblastomaon June 21, 2020 at 5:01 pm
Sonodynamic therapy with focused ultrasound offers a new therapeutic approach to treating patients with malignant brain tumors. This approach combines two approved options, [the drug] 5-ALA and ...
- Stroke survival rates worse in rural areas, study sayson June 18, 2020 at 12:55 pm
The clot-busting drugs must be administered within the first three hours after the onset of symptoms, such as face drooping and slurred speech, and endovascular therapy must be given ... medical news ...
- CBD may improve steroid therapy in autoimmune, Covid-19 patientson June 17, 2020 at 10:59 pm
The primary therapy for GvHD is also steroids ... He was a successful software entrepreneur when his mother was diagnosed with multiple myeloma, a deadly blood cancer. In looking for a drug that could ...
- Busting Patient Recruitment Bottlenecks in Oncology Trialson June 17, 2020 at 10:28 am
How integrated data platforms can help find the best-suited patients for cancer studies and reduce the burden on care teams.
- Cancer patients less likely to be prescribed cardioprotective medicationson June 16, 2020 at 11:02 am
Cancer patients had lower utilization rates of antiplatelet therapies and statins compared to non-cancer patients. Cancer patients were also more likely to have been admitted to the hospital for ...
- ‘We’ve got to be able to move more quickly.’ The pandemic reality of COVID-19 clinical trialson June 16, 2020 at 9:54 am
They are testing everything from clot-busting drugs to monoclonal antibodies ... more patients are allocated to therapies that appear most promising. Neil Schluger is chief of the division of ...
via Bing News